Related Experiment Videos
Variations in local PGE levels: a potential factor in therapeutic responsiveness?
C Hammerman1, R Arcilla, K C Bui
1Department of Pediatrics, University of Chicago Medical Center, Illinois.
Pediatric Cardiology
|April 1, 1991
Summary
Prostaglandin E1 (PGE1) levels reaching the ductus arteriosus are critical for treatment response in infants with congenital heart defects. Infusion site and patient hemodynamics significantly impact these crucial PGE1 levels.
Area of Science:
- Neonatal cardiology
- Pharmacology
- Pediatric cardiovascular research
Background:
- Prostaglandin E1 (PGE1) is vital for maintaining ductus arteriosus patency in neonates with specific congenital heart lesions.
- The efficacy of PGE1 infusions is presumed to depend on achieving adequate concentrations at the ductus arteriosus.
Observation:
- This study investigated site-specific Prostaglandin E1 (PGE1) levels in two infants with ductus-dependent congenital heart disease receiving PGE1 infusions.
- PGE1 levels were measured in relation to infusion site, cardiac anatomy, and patient hemodynamics.
Findings:
- Plasma PGE1 concentrations varied significantly based on the infusion site and individual patient cardiac anatomy and hemodynamics.
- In one patient with a double outlet right ventricle and significant ductal shunting, intra-arterial PGE1 infusion resulted in negligible PGE1 levels in ductal blood.
Implications:
- Site-specific PGE1 concentrations are critical for therapeutic success in ductus arteriosus management.
- Consideration of hemodynamics and infusion site is essential when initiating PGE1 therapy or assessing treatment failure in neonates with congenital heart defects.